Novavax, Inc. is a clinical-stage biopharmaceutical company, which engages in development of novel recombinant vaccines to address a broad read more

EMPLOYEE PARTICIPANTS: 14

TOTAL RATINGS: 148

CEO: Stanley Erck

Novavax Executive Team

The Novavax Executive Team is rated a "C-" and led by CEO Stanley Erck. Novavax employees rate their Executive Team in the Bottom 35% of similar size companies on Comparably with 201-500 Employees.

Out of their 1 competitor, Alnylam Pharmaceuticals, Novavax's score ranks in 2nd place.

Last updated months ago.

Where This Score Ranks Novavax's Executive Team

BOTTOM
35%
In the Bottom 35% of 1623 Similar Sized Companies on Comparably
BOTTOM
35%
In the Bottom 35% of 177 Nearby Companies in Washington, DC
2nd
2nd place versus 1 competitors rated on Comparably

Jun

Dec

Apr

Jul

C-62 / 100

Jan

Novavax Key Executives

Name & Title

Bio

Who Ranks Novavax's Executive Team the Highest?

Not Enough Ratings To Show Who Ranks Executive Team the Highest

Anonymously rate my experience at Novavax

Who Ranks Novavax's Executive Team the Lowest?

Not Enough Ratings To Show Who Ranks Executive Team the Lowest

Anonymously rate my experience at Novavax

Novavax's Executive Team Trendline

Novavax60
Other Companies in Washington, DC
Similar Size on Comparably

Novavax Executive Team At a Glance

The Executive Team Score of 62/100 is calculated by combining aggregate responses to the questions of “How would you rate your executive team?” and “Do you approve of the job your executive team is doing at your company?”

100% of employees say “Yes, they approve of the job the executive team is doing at Novavax.”

The last rating scoring Novavax's executive team was provided months ago and has remained stable at 62 over the last 90 days.